Showing results (511-520 of 586) with videos related to

Sort By:
Pageof 59
Scientific Reports|March 19, 2020
Author Correction: Extensive genomic diversity among Mycobacterium marinum strains revealed by whole genome sequencingSarbashis Das, B M Fredrik Pettersson, Phani Rama Krishna Behra, et al.
The Journal of Experimental Medicine|March 9, 2018
Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiationDifeng Fang, Kairong Cui, Gangqing Hu, et al.
Current Problems in Cardiology|August 28, 2023
Exploring Transthyretin Amyloid Cardiomyopathy: A Comprehensive Review of the Disease and Upcoming TreatmentsHritvik Jain, Murali Mohan Rama Krishna Reddy, Rohit Chandra Dey, et al.
Molecular Cancer|February 27, 2020
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistanceRamesh Pothuraju, Satyanarayana Rachagani, Shiv Ram Krishn, et al.
Bioresource Technology|August 13, 2023
Biochar production and its environmental applications: Recent developments and machine learning insightsKolli Venkata Supraja, Himanshu Kachroo, Gayatri Viswanathan, et al.
The Lancet Regional Health. Southeast Asia|June 18, 2025
Outcomes of children with juvenile idiopathic arthritis receiving biological disease-modifying anti-rheumatic drugs: a retrospective single-centre experience from IndiaPavneet Kaur, Farheen Kizhakkeveettil Saheer, Bala Siva Rama Krishna J, et al.
Bioorganic & Medicinal Chemistry|September 30, 2011
1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4Alexander L Ruchelman, Hon-Wah Man, Roger Chen, et al.
The Journal of Infectious Diseases|September 22, 2011
Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T-cell responseUthaman Gowthaman, Vijender Singh, Weiguang Zeng, et al.
Toxicology and Applied Pharmacology|September 1, 2022
Estimated sensitivity profiles of lung cancer specific uncommon BRAF mutants towards experimental and clinically approved kinase inhibitorsSai Charitha Mullaguri, Sravani Akula, Vigneshwar Reddy Ashireddygari, et al.
Pageof 59